Allspring Global Investments
ITCI

Allspring Global Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Allspring Global Investments’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,631
Closed -$2.41M – 1842
2024
Q4 		$2.41M Buy
28,631
+26,776
+1,443% +$2.2M ﹤0.01% 1107
2024
Q3 		$136K Sell
1,855
-67,841
-97% -$5.1M ﹤0.01% 1735
2024
Q2 		$4.77M Buy
69,696
+53,322
+326% +$3.7M 0.01% 967
2024
Q1 		$1.13M Sell
16,374
-6,649
-29% -$457K ﹤0.01% 1337
2023
Q4 		$1.65M Sell
23,023
-5,638
-20% -$324K ﹤0.01% 1228
2023
Q3 		$1.49M Buy
28,661
+24,607
+607% +$1.43M ﹤0.01% 1265
2023
Q2 		$257K Sell
4,054
-3,424
-46% -$213K ﹤0.01% 1728
2023
Q1 		$405K Sell
7,478
-1,428
-16% -$69K ﹤0.01% 1634
2022
Q4 		$471K Sell
8,906
-45,323
-84% -$2.27M ﹤0.01% 1610
2022
Q3 		$2.52M Buy
54,229
+45,454
+518% +$2.37M ﹤0.01% 1167
2022
Q2 		$500K Sell
8,775
-10,954
-56% -$621K ﹤0.01% 1582
2022
Q1 		$1.21M Sell
19,729
-33
-0.2% -$1.71K ﹤0.01% 1775
2021
Q4 		$1.03M Buy
+19,762
New +$830K ﹤0.01% 1919

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Allspring Global Investments's ITCI Position: Q1 2025 in Review

Allspring Global Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 28,631 shares — an estimated $2.41M sold.

Allspring Global Investments first reported a position in ITCI in Q4 2021 and held it in 13 quarters. The position peaked at $4.77M in Q2 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Allspring Global Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Allspring Global Investments sold 28,631 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $2.41M.
  • Allspring Global Investments first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 13 quarters.
  • Allspring Global Investments's Intra-Cellular Therapies Inc. position peaked at $4.77M in Q2 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Allspring Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.